The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients.
NCT03163316 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2021-08-03
Summary
Breast cancer is the most common cancer among women worldwide.The main cause of cancer related death is the invasion and metastasis. The usual site of spread outside the breast is to lymph nodes in the axilla.
Conditions
- Breast Cancer Female
Interventions
- OTHER
-
Unenhanced magnetic resonance imaging.
The axillary lymph nodes will be evaluated on axial Time 1-weighted images obtained without fat saturation. We will measure the largest dimension and cortical thickness of each lymph node and ratio of the two measurements will be calculated. The lymph nodes seen in Time 1-weighted images will be subsequently identified on the diffusion-weighted images to calculate the apparent diffusion coefficient value of each lymph node. Axillary lymph nodes scanned by magnetic resonance imaging will be compared by results of histopathological examination.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Sandy HN Ghaly, MBBCh · Assiut University
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2021-06-01
- Completion
- 2021-07-01
Countries
- Egypt
Study Locations
More Related Trials
-
Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics
NCT05826197 ·Status: UNKNOWN
-
Diffusion Weighted MRI for Lymphnodes in the Axilla
NCT00276211 ·Status: COMPLETED
-
Breast Lesion in CT Chest
NCT06196216 ·Status: ACTIVE_NOT_RECRUITING
-
Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI
NCT04826211 ·Status: COMPLETED ·Phase: NA
-
68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer
NCT06559371 ·Status: RECRUITING
-
MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)
NCT04004559 ·Status: UNKNOWN
-
Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer
NCT03474016 ·Status: UNKNOWN
-
Diffusion Magnetic Resonance Imaging in Mamographically Detected Asymmetric Densities
NCT03696147 ·Status: UNKNOWN
-
Sentinel Node Biopsy Vs Observation After Axillary PET
NCT04072653 ·Status: RECRUITING ·Phase: NA
-
PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients
NCT03374826 ·Status: RECRUITING ·Phase: NA
-
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative
NCT01642511 ·Status: COMPLETED ·Phase: PHASE2
-
Axillary Staging in Early Breast Cancer: SNB vs PET/MRI
NCT04829643 ·Status: COMPLETED ·Phase: NA
-
Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy
NCT05301790 ·Status: UNKNOWN
-
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
NCT05703295 ·Status: UNKNOWN
-
Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive
NCT01668914 ·Status: COMPLETED ·Phase: PHASE3
-
Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer
NCT05141630 ·Status: UNKNOWN ·Phase: PHASE2
-
The Value of High-resolution Ultrasound in the Detection of Lymph Node Metastasis: a Proposal of NI-RADS
NCT03791840 ·Status: COMPLETED
-
Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Breast Cancer.
NCT03681418 ·Status: UNKNOWN ·Phase: NA
-
Correlation Between PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer
NCT05064475 ·Status: UNKNOWN
-
Breast Masses MRI Volumetry Compared to Post-operative Pathological Volume
NCT07268300 ·Status: NOT_YET_RECRUITING
-
Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images
NCT06510738 ·Status: NOT_YET_RECRUITING
-
Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer
NCT04882371 ·Status: COMPLETED
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC
NCT04457700 ·Status: UNKNOWN
-
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
NCT06001528 ·Status: RECRUITING